The neurological assessment in young children treated with artesunate monotherapy or artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria

BACKGROUND: Mefloquine and artesunate combination therapy is the recommended first-line treatment for uncomplicated malaria throughout much of south-east Asia. Concerns have been raised about the potential central nervous system (CNS) effects of both drug components and there are no detailed reports...

Descripción completa

Detalles Bibliográficos
Autores principales: Ambler, Michael T, Dubowitz, Lilly M, Arunjerdja, Ratree, Hla, Eh Paw, Thwai, Kyaw Lay, Viladpainguen, Jacher, Singhasivanon, Pratap, Luxemburger, Christine, Nosten, François, McGready, Rose
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2743706/
https://www.ncbi.nlm.nih.gov/pubmed/19725966
http://dx.doi.org/10.1186/1475-2875-8-207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2743706/
https://www.ncbi.nlm.nih.gov/pubmed/19725966
http://dx.doi.org/10.1186/1475-2875-8-207

Ejemplares similares